Isolation of epithelial cells from breast tumor specimens and application of specific functional DNA repair assay systems led to the detection of specific defects in double strand breaks repair [22], while homologous recombination status could be determined in ovarian cancer samples by RAD51 foci formation after in vitro treatment with a PARP inhibitor [23]. The gene discussed is PARP1; the disease is ovarian carcinoma.